---
schema_version: "secwatch.filing_event.v1"
accession: "0001570562-21-000177"
form_type: "8-K"
ticker: "EOLS"
cik: "0001570562"
company_name: "Evolus, Inc."
filed_at: "2021-12-14T23:59:59+00:00"
generated_at: "2026-06-28T01:17:05.280496+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolus enters $125M credit facility with Pharmakon Advisors; initial $75M draw

## Summary
- $75M drawn at close; up to $50M additional tranche available until Dec 31, 2022.
- Facility matures in 6 years, interest-only for first 39 months; rate = 3-month LIBOR (1% floor) + 8.5%.
- Proceeds for general corporate, working capital, and potential strategic transactions.
- Company expects initial tranche to fund operations beyond cash flow breakeven, removing near-term equity dilution.

## SEC filing metadata
- accession: 0001570562-21-000177
- form_type: 8-K
- ticker: EOLS
- cik: 0001570562
- company_name: Evolus, Inc.
- filed_at: 2021-12-14T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1570562/000157056221000177/0001570562-21-000177-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1570562/000157056221000177/eols-20211214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001570562-21-000177
- JSON: https://secwatch.observer/filing/0001570562-21-000177.json
- Plain text: https://secwatch.observer/filing/0001570562-21-000177.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.